# Tiotropium (Spiriva) Rehabilitation Study

> **NCT00274521** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 108 (—)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Tiotropium

## Key facts

- **NCT ID:** NCT00274521
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** 2003-02
- **Final completion:** —
- **Target enrollment:** 108 (—)
- **Last updated:** 2013-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00274521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00274521, "Tiotropium (Spiriva) Rehabilitation Study". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00274521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*